Amneal Pharmaceuticals In... (AMRX)
NASDAQ: AMRX
· Real-Time Price · USD
9.37
-0.02 (-0.21%)
At close: Aug 15, 2025, 3:04 PM
Amneal Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 724.51M | 695.42M | 730.52M | 702.47M | 701.78M | 659.19M | 616.98M | 620.04M | 599.05M | 557.54M | 609.76M | 545.56M | 559.36M | 497.63M | 536.9M | 528.59M | 535.08M | 493.11M |
Cost of Revenue | 438.25M | 439.53M | 467.64M | 432.91M | 451.83M | 421.13M | 380.5M | 387.51M | 379.02M | 379.35M | 394.37M | 351.33M | 358.84M | 323.06M | 370.49M | 330.08M | 322.58M | 301.54M |
Gross Profit | 286.25M | 255.89M | 262.87M | 269.56M | 249.95M | 238.06M | 236.48M | 232.53M | 220.02M | 178.19M | 215.39M | 194.23M | 200.52M | 174.57M | 166.4M | 198.51M | 212.5M | 191.56M |
Operating Income | 111.37M | 100.35M | 75.79M | 88.81M | 95.47M | -10.75M | 14.19M | 75.65M | 80.08M | 34.45M | 74.2M | 44.35M | -198.62M | 23.3M | 11.18M | 28.52M | 67.12M | 45.91M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 49.31M | 47.03M | 42.39M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 51.71M | 37.49M | -15.32M | 15.42M | 20.41M | -75.52M | -83.46M | 22.96M | 29.66M | -9.43M | -7.66M | 2.18M | -232.73M | -9.92M | -16.32M | -2.04M | 34.82M | 14.9M |
Net Income | 22.42M | 12.2M | -31.08M | -156K | 5.99M | -91.64M | -98.65M | 9.68M | 11.92M | -10.09M | -5.86M | -2.39M | -120.81M | -6.46M | -6.38M | -4.24M | 14.53M | 6.71M |
Selling & General & Admin | 124.27M | 118.29M | 128.69M | 118.69M | 116.46M | 112.59M | 109M | 113.01M | 105.57M | 102.1M | 102.16M | 100.07M | 98.81M | 98.67M | 97.22M | 91.4M | 86.16M | 90.73M |
Research & Development | 47.96M | 41.81M | 56.12M | 61.1M | 37.1M | 39.3M | 46.56M | 42.26M | 38.62M | 40.33M | 43.27M | 51.65M | 51.57M | 53.56M | 53.02M | 50.55M | 54.23M | 51.76M |
Other Expenses | 2.02M | -4.55M | 2.28M | 960K | 919K | n/a | 411K | 1.62M | -4.25M | -1.22M | -1.47M | -1.32M | n/a | n/a | n/a | n/a | n/a | 794K |
Operating Expenses | 174.25M | 155.54M | 187.08M | 180.75M | 154.48M | 151.89M | 155.57M | 156.88M | 139.94M | 141.21M | 143.96M | 150.4M | 149.2M | 152.23M | 150.24M | 141.95M | 140.39M | 142.49M |
Interest Expense | 65.1M | 56.94M | 61.66M | 65.51M | 65.72M | 65.7M | 59.55M | 50.91M | 50.86M | 49.31M | 47.03M | 42.39M | 35.62M | 33.34M | 33.96M | 34.4M | 34.08M | 33.88M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 610.49M | 595.07M | 654.73M | 613.66M | 606.31M | 573.02M | 602.79M | 544.39M | 518.96M | 520.56M | 538.33M | 501.72M | 508.04M | 475.29M | 520.73M | 472.03M | 462.96M | 444.03M |
Income Tax Expense | 16.1M | 12.87M | 5.42M | 3.67M | 3.62M | 6.16M | 9.88M | -2.08M | -23K | 668K | -1.8M | 4.57M | 7.35M | -3.46M | 4.14M | 4.05M | 2.65M | 359K |
Shares Outstanding (Basic) | 313.74M | 311.05M | 309.85M | 309.65M | 309.12M | 305.48M | 243.71M | 161.37M | 153.74M | 152.11M | 151.48M | 151.39M | 150.99M | 149.89M | 149.37M | 149.29M | 149M | 148.01M |
Shares Outstanding (Diluted) | 322.36M | 323.96M | 309.85M | 309.65M | 318.96M | 307.28M | 243.71M | 159.69M | 154.89M | 152.11M | 151.48M | 151.39M | 150.99M | 149.89M | 149.37M | 149.29M | 151.99M | 151.22M |
EPS (Basic) | 0.07 | 0.04 | -0.1 | -0.00 | 0.02 | -0.3 | -0.4 | 0.06 | 0.08 | -0.07 | -0.04 | -0.02 | -0.8 | -0.04 | -0.04 | -0.03 | 0.10 | 0.05 |
EPS (Diluted) | 0.07 | 0.04 | -0.1 | -0.00 | 0.02 | -0.3 | -0.4 | 0.06 | 0.08 | -0.07 | -0.04 | -0.02 | -0.8 | -0.04 | -0.04 | -0.03 | 0.10 | 0.04 |
EBITDA | 176.93M | 154.58M | 112.47M | 139.9M | 151.96M | 140.71M | 138.32M | 131.07M | 137.63M | 106.13M | 137.81M | 106.14M | -137.41M | 80.16M | 99.35M | 117.43M | 128.6M | 104.62M |
EBIT | 116.81M | 94.42M | 46.34M | 80.93M | 86.12M | -9.82M | 81.39M | 73.87M | 80.52M | 39.89M | 39.37M | 44.57M | -197.11M | 23.41M | 17.64M | 32.36M | 68.91M | 48.79M |
Depreciation & Amortization | 60.11M | 60.16M | 66.13M | 58.96M | 55.57M | 55.53M | 56.93M | 57.21M | 57.11M | 58.15M | 61.06M | 61.61M | 59.7M | 57.81M | 61.18M | 60.19M | 56.49M | 55.55M |